Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
Conditions
- Current or Recent History of Atrial Fibrillation
Interventions
- DRUG: bucindolol hydrochloride
- DRUG: metoprolol succinate
- OTHER: Placebo oral capsule
Sponsor
ARCA Biopharma, Inc.
Collaborators